These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7018235)

  • 1. Physiologic basis of vasodilator therapy for heart failure.
    Cohn JN
    Am J Med; 1981 Jul; 71(1):135-9. PubMed ID: 7018235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention.
    Francis GS; Cohn JN
    FASEB J; 1990 Oct; 4(13):3068-75. PubMed ID: 2210153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohumoral control mechanisms in congestive heart failure.
    Cohn JN; Levine TB; Francis GS; Goldsmith S
    Am Heart J; 1981 Sep; 102(3 Pt 2):509-14. PubMed ID: 6115571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unloading the heart in congestive heart failure.
    Cohn JN
    Am J Med; 1984 Aug; 77(2A):67-70. PubMed ID: 6383033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiocirculatory dynamics in the normal and failing heart.
    Zelis R; Flaim SF; Liedtke AJ; Nellis SH
    Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bromocriptine in patients with congestive heart failure.
    Francis GS; Parks R; Cohn JN
    Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
    Malacco E; Limonta A; Milanesi A; Micossi P
    Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions in vasodilator therapy for heart failure.
    Cohn JN
    Am Heart J; 1991 Mar; 121(3 Pt 1):969-74. PubMed ID: 2000775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hemodynamic changes on neuroendocrine response in acute heart failure.
    Pohar B; Horvat M
    Int J Cardiol; 1997 Aug; 60(3):263-71. PubMed ID: 9261637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.